Letter to the Editor: sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis

Journal of Dermatological Treatment 2026 Open access

Read full text
Authors: Yusra Hidayat
DOI: 10.1080/09546634.2026.2690324
Cited by: 1
References: 4

Abstract

We read with great interest the post-hoc analysis by Guttman-Yassky et al. reporting that 21.3% of patients with moderate-to-severe atopic dermatitis (AD) remained free of protocol-defined flare fo...

Fields of Study & Subjects

Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Hidradenitis Suppurativa and Treatments

Publication details

Journal / source
Journal of Dermatological Treatment
Publisher
Informa UK Limited
Volume
37
Issue
1
Pages
2690324–2690324
Publication date
18 June 2026
Language
EN